Silo Pharma Inc. (NASDAQ:SILO) shares traded -5.45% lower at $1.91 on Wall Street last session.
SILO stock price is now -25.86% away from the 50-day moving average and -60.67% away from the 200-day moving average. The market capitalization of the company currently stands at $6.28M.
From Robots to Self-Driving Cars: 5 AI Stocks to Consider for Your Portfolio
The artificial intelligence (AI) revolution is already here and it's about to change everything we know about everything. With the global market for AI projected to grow from $137 billion in 2022 to over $1.81 trillion by 2030, there's never been a better time to invest in this burgeoning industry. That's why we've compiled a list of the Top 5 AI Stocks to Buy for 2023. These companies are at the forefront of the AI revolution, and have the potential to deliver huge returns to investors like you.
Get our free report, "Top 5 AI Stocks to Buy for 2023".
Sponsored
.
In other news, Weisblum Eric, CEO and President bought 130 shares of the company’s stock on Dec 20. The stock was bought for $354 at an average price of $2.72. Upon completion of the transaction, the CEO and President now directly owns 154,854 shares in the company, valued at $0.3 million. An SEC document containing details of the transaction can be found on the SEC’s website. On Dec 19, CEO and President Weisblum Eric bought 200 shares of the business’s stock. A total of $536 was incurred on buying the stock at an average price of $2.68. This leaves the insider owning 154,724 shares of the company worth $0.3 million. A total of 5.10% of the company’s stock is owned by insiders.
There have been several recent changes in the stakes of large investors in SILO stock. A new stake in Silo Pharma Inc. shares was purchased by FINANCIAL ADVOCATES INVESTMENT MANAGEMENT during the first quarter worth $29,000. TOWER RESEARCH CAPITAL LLC (TRC) invested $2,000 in shares of SILO during the first quarter. In total, there are 3 active investors with 1.60% ownership of the company’s stock.
Silo Pharma Inc. (NASDAQ: SILO) opened at $2.3000 on Wednesday. During the past 12 months, Silo Pharma Inc. has had a low of $1.98 and a high of $12.44. The fifty day moving average price for SILO is $2.5472 and a two-hundred day moving average price translates $4.7584 for the stock.
The latest earnings results from Silo Pharma Inc. (NASDAQ: SILO) was released for Sep, 2022. The company reported revenue of $18000.0 for the quarter, compared to $18000.0 a year earlier.
Silo Pharma Inc.(SILO) Company Profile
Silo Pharma. Inc., a developmental stage biopharmaceutical company, focuses on merging traditional therapeutics with psychedelic research. It is developing solutions to address various underserved conditions. The company seeks to acquire and/or develop intellectual property or technology rights from universities and researchers to treat rare diseases, including the use of psychedelic drugs, such as psilocybin, and the benefits they may have in certain cases involving depression, mental health issues, and neurological disorders. The company focuses on merging traditional therapeutics with psychedelic research for people suffering from indications, such as depression, post-traumatic stress disorder, Alzheimer’s, Parkinson’s, and other rare neurological disorders. The company was formerly known as Uppercut Brands, Inc. and changed its name to Silo Pharma, Inc. in September 2020. Silo Pharma, Inc. was incorporated in 2010 and is headquartered in Englewood Cliffs, New Jersey.
